Submit your Abstract

Review the submission guidelines

Please carefully read the below Guidelines for the preparation of your abstract.

Guidelines for preparation of abstracts

1. Online submission only – Abstracts sent by fax or email will not be accepted
2. Authors should indicate their presentation type preference:

1. • Poster presentation only
   • Oral or Poster presentation

Note: “Poster presentation only” implies that your abstract will be considered for poster presentation only and will not be selected for an Oral session.

3. One person may serve as presenting author on up to 5 abstracts.
4. The Scientific Programme Committee reserves the right to decide on the final allocation and presentation method.
5. All abstracts should be submitted and presented in clear UK English with accurate grammar and spelling of a quality suitable for publication. If you need help, arrange for the review of your abstract by a colleague who is a native English speaker, by a university specific publications office (or other similar facility) or by a copy editor, prior to submission.
6. You may enter up to 15 authors in the authors list including the Presenter.
   If you have more than 15 authors, you can use the “On behalf of” field to enter the name of an investigating team/study group
7. The presenting author of an accepted abstract must register and attend the congress to ensure the publication of abstracts.
8. Submission of an abstract acknowledges your acceptance for the abstract to be published in the official conference publications.
9. The presenting author is required to ensure that all co-authors are aware of the content of the abstract and agree to its submission, before submitting the abstract.
10. Abstracts that have been previously presented at another international meeting cannot be considered for a plenary session.
11. Abstract title – must be in UPPER CASE and limited to 25 words. Please submit symbols as words.
12. Abstract text – limited to 250 words including acknowledgements. Note that word count is affected when tables are included. Tables (3 max) may be added at the end of the template (word file).
13. Abstracts should clearly state:
    Background and aims
    Methods
    Results
    Conclusions 
14. Use only standard abbreviations. Place special or unusual abbreviations in parentheses after the full word the first time it appears.
15. Use generic names of drugs. The presentation must be balanced and contain no commercial promotional content.
16. Images – The maximum file size of each image is 500 KB. The maximum pixel size of the graph/image is 600(w) x 800(h) pixel. You may upload images in JPG, GIF or PNG format. Images (3 max) may be added at the end of the template (word file).
17. Submissions may not contain patient names, hospital ID numbers or other identifying information.
18. Disclosure of Conflicts of Interest: Please disclose any conflict of interests the authors might have and indicate in the according selection. If none, do not include any information
19. Important:

As the grading and selection process is blind, the title and body text must not contain identifying features, i.e. information such as:

• Names (authors or others)
• Names of the institutes (hospitals, medical schools, clinics…)
• Cities

20. Make sure to state your correct e-mail After having submitted your abstract, you will receive a confirmation by e-mail with the following information:

• reference number of your abstract (for correspondence and questions that might arise)
• title of your submitted abstract

If you do not receive a confirmation by e-mail, please contact ESOC.abstracts@congrex.com.

21. Should you wish to make corrections to an abstract already submitted or if you wish to submit other abstracts later, you may use your personal log-in. This will shorten the submission procedure.

Corrections to abstracts can only be made up to the deadline of 14 January 2025, 23.59h CET.

Notification
Each abstract will be reviewed and rated by at least 4 external blinded experts and final selection will be made by the Scientific Programme Committee. Notification of acceptance or rejection of submitted abstracts will be sent to the corresponding authors via email by end of March 2025. Full instructions concerning preparation and presentation will be included and will be made available on the conference website.

Publication
Publication Embargo: ESOC 2025 has an embargo policy on all abstracts submitted to the conference. The embargo will be lifted on 21 May 2025. All accepted abstracts will be published in the peer-reviewed journal.

Questions?
If you have questions regarding abstracts technical questions or need assistance, contact the abstract team at ESOC.Abstracts@congrex.com including/referring to the name of the congress.
Abstract hotline: +41 61 686 77 22 (Monday – Friday during CET business hours)